PREVOTELLA HISTICOLA STRAIN C AS AN ORAL THERAPY FOR INFLAMMATORY DISEASES

Provided herein are methods and pharmaceutical compositions related to the bacteria and microbial extracellular vesicles (mEVs) of Prevotella histicola Strain C that are useful as therapeutic agents, e.g., for treating inflammatory diseases (e.g., a neuroinflammatory disease). L'invention conce...

Full description

Saved in:
Bibliographic Details
Main Authors PONICHTERA, Holly, KRAVITZ, Valeria, WARDWELL-SCOTT, Leslie, BODMER, Mark, RAMANI, Kritika, CORMACK, Taylor, CAFFRY, William, PACHECO, Alline, SIZOVA, Maria
Format Patent
LanguageEnglish
French
Published 27.01.2022
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Provided herein are methods and pharmaceutical compositions related to the bacteria and microbial extracellular vesicles (mEVs) of Prevotella histicola Strain C that are useful as therapeutic agents, e.g., for treating inflammatory diseases (e.g., a neuroinflammatory disease). L'invention concerne des procédés et des compositions pharmaceutiques associés aux bactéries et aux vésicules extracellulaires microbiennes (mEV) de la souche C de Prevotella histicola qui sont utiles en tant qu'agents thérapeutiques, par exemple pour le traitement de maladies inflammatoires (par exemple, une maladie neuro-inflammatoire).
Bibliography:Application Number: WO2021US42396